Overview
Seed-stage venture capital firm investing in life sciences and efficiency.
Founded
2020
Deals ยท 12mo
0
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
HDAX Therapeutics | Sep 2024Led | $3 MSeed | |
Vasa Therapeutics | Jan 2024Participated | $8 MSeed | |
Interface Biosciences | Dec 2023Led | $3 MSeed | |
Trio Pharmaceuticals | Apr 2023Participated | $2 MSeed | |
Tiamat Sciences | Mar 2023Participated | $2 MSeed | |
VerImmune | Jul 2022Led | $3 MSeed | |
Veckta | Jul 2022Participated | $3 MSeed | |
Allotrope Medical | Jun 2021Participated | $4 MSeries A | |
HDAX Therapeutics | Sep 2024Led | $3 MSeed | |
Vasa Therapeutics | Jan 2024Participated | $8 MSeed | |
Interface Biosciences | Dec 2023Led | $3 MSeed | |
Trio Pharmaceuticals | Apr 2023Participated | $2 MSeed | |
Tiamat Sciences | Mar 2023Participated | $2 MSeed | |
VerImmune | Jul 2022Led | $3 MSeed | |
Veckta | Jul 2022Participated | $3 MSeed | |
Allotrope Medical | Jun 2021Participated | $4 MSeries A |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 3 | 4 |
| Series A | 0 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Jun '21 | 1 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 2 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 1 |
| Apr '23 | 1 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 1 |
| Jan '24 | 1 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 1 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 7 |
| Food & Agriculture | 1 |
| Clean Energy & Sustainability | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 7 |
| $5M-$10M | 1 |
| $10M-$25M | 0 |
| $25M-$50M | 0 |
| $50M-$100M | 0 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 7 |
| Canada | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Gaingels | 2 |
| NuFund Venture Group | 2 |
| Tech Coast Angels | 2 |
| Ulu Ventures | 2 |
| 8090 Industries | 1 |
| Aggie Angel Network | 1 |
| Alexandria Venture Investments | 1 |
| Bellingham Angel Investors | 1 |
| Berkeley Angel Network | 1 |
| Boom Capital | 1 |
| Cantos | 1 |
| Cove Fund | 1 |
| Eos Bioinnovation | 1 |
| Exponential Impact | 1 |
| FACIT | 1 |
| Friedman BioVentures | 1 |
| Kentucky Select Fund | 1 |
| LongeVC | 1 |
| Mana Ventures | 1 |
| MEDA Angels | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 3 | 38% |
| Participating | 5 | 63% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 33% |
| Co-led | 2 | 67% |
Team
Managing Director